Clinical Trials Logo

Early-Onset Sepses, Neonatal clinical trials

View clinical trials related to Early-Onset Sepses, Neonatal.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04050488 Not yet recruiting - Clinical trials for Bronchopulmonary Dysplasia

Zinc Supplementation on Very Low Birth Weight Infant

Start date: August 20, 2019
Phase: Phase 4
Study type: Interventional

Premature birth is a major cause of neonatal death in addition to neonatal asphyxia and infections. Early in life, premature babies must get aggressive nutrition so that there is no extrauterine growth restriction (EUGR) in the Intrauterine Growth Restriction (IUGR) group compared to the non-IUGR group. Other factors that also play a role are long episodes of fasting, the fulfillment of nutrition (macro and micronutrients) from the start, time to start breastfeeding (ASI), duration of parenteral total administration, the incidence of respiratory distress syndrome and incidence of necrotizing enterocolitis. Zinc is one of the micronutrients which is very risky for deficiency in premature babies. Babies with zinc deficiency experience growth disorders as much as 67%. In India, infants who received zinc supplementation increased after being given 10 days of zinc supplementation and lower mortality rates in the group with supplementation. Very low birth weight babies and bronchopulmonary dysplasia who received zinc supplementation during the week showed good clinical progress and the growth rate also increased. The investigators believe this study has the potential for decreasing infant mortality from its current level and can be a growth indicator for preterm babies.